Condition
Inhaled Corticosteroid
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed1
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07507435Not ApplicableNot Yet Recruiting
Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults
NCT04481555Phase 4Completed
Eosinophil-guided Reduction of Inhaled Corticosteroids
NCT04456205Unknown
Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease (COPD)
Showing all 3 trials